Cilostazol (Carilion Materials Management)
Welcome to the PulseAid listing for the Cilostazol drug offered from Carilion Materials Management. This Phosphodiesterase 3 Inhibitor [EPC],Phosphodiesterase 3 Inhibitors [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Carilion Materials Management |
NON-PROPRIETARY NAME: | Cilostazol |
SUBSTANCE NAME: | CILOSTAZOL |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Phosphodiesterase 3 Inhibitor [EPC],Phosphodiesterase 3 Inhibitors [MoA] |
ROUTE: | ORAL |
DOSAGE FORM: | TABLET |
MARKETING CATEGORY NAME: | ANDA |
START MARKETING DATE: | 2005-05-17 |
END MARKETING DATE: | 0000-00-00 |
Cilostazol HUMAN PRESCRIPTION DRUG Details:
Item Description | Cilostazol from Carilion Materials Management |
LABELER NAME: | Carilion Materials Management |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 50(mg/1) |
START MARKETING DATE: | 2005-05-17 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 68151-3844_211b3b29-35eb-460c-962b-eba72c1b070a |
PRODUCT NDC: | 68151-3844 |
APPLICATION NUMBER: | ANDA077024 |
Other CILOSTAZOL Pharmaceutical Manufacturers / Labelers: